Healthcare  Name:  Sector:  COO: Gloucester Pharmaceuticals Healthcare John McBride  Summary: Development stage cancer company with a novel histone deacetylase inhibitor in advanced clinical trials.  Stage of Initial  Investment: Venture  Liquidity: Private One Broadway, 14th Floor Cambridge, MA 02142 Phone: 617.583.1300 Fax: 617.583.1368
	Copyright ©2007 Rho Capital Partners, Inc.